Charles Semba

Chief Medical Officer and Board Member. Developing global innovative protein therapeutics for vision-threatening diseases and tissue generation/dermal facial aesthetics. Look better. See better.

Role
Board Member at DiaMedica Therapeutics Inc.
Location
Mountain View, CA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Charles Semba

25 years in therapeutic product development in public (Genentech/Roche, Shire/Takeda) and private companies (SARcode Biosciences, ForSight VISION5, Graybug Vision); small molecules, biologics, sustained-release, drug delivery; ocular surface, glaucoma, retinal diseases and collagen-based medical devices.

Experience

  1. Board Member

    DiaMedica Therapeutics Inc.

    Jul 2021 — Present · Minneapolis, MN, US

    DiaMedica Therapeutics is a clinical-stage biopharmaceutical company committed to changing the treatment paradigm for high-risk pregnancy (preeclampsia, fetal growth restriction), acute ischemic stroke (AIS) and chronic kidney disease (CKD). DiaMedica’s lead candidate DM199 is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality for the treatment of preeclampsia, acute ischemic stroke and chronic kidney disease.

Education

  • UC San Diego

    Diagnostic Radiology

    1987 — 1991

  • Miami Cardiac & Vascular Institute

    Fellow, Vascular and Interventional Radiology

    1991 — 1992

  • Carleton College

    BA, Chemistry

    1977 — 1981

  • University of Minnesota Medical School

    MD

    1982 — 1986

Skills

  • R&D
  • Ophthalmology
  • Clinical Trials
  • Commercialization
  • Medical Affairs
  • Regulatory Affairs
  • Lifesciences
  • Drug Discovery
  • Biotechnology
  • Research and Development (R&D)
  • Good Clinical Practice (Gcp)
  • Therapeutic Areas
  • U.s. Food and Drug Administration (Fda)
  • Medicine
  • Product Launch
  • Endocrinology
  • Immunology
  • Medical Imaging
  • Drug Development
  • Gcp
  • Biopharmaceuticals
  • Pharmacovigilance
  • Protocol
  • Molecular Biology
  • Life Sciences
  • Pharmaceutical Industry
  • Fda
  • Clinical Development
  • Medical Devices
  • Clinical Research
  • Regulatory Submissions

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Charles Semba — Board Member at DiaMedica Therapeutics Inc. in Mountain View, CA, US | Unifers